NCT01742975View on ClinicalTrials.gov

Efficacy Study of Ifabond in Breast Cancer Surgery

NACompletedINTERVENTIONAL
Enrollment

104

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

April 30, 2015

Study Completion Date

February 29, 2016

Conditions
Breast CancerLymphocele
Interventions
DEVICE

IFABOND (TM)

The synthetic adhesive solution Ifabond, will be applied at the end of conventional breast cancer surgery for arm A patients

Trial Locations (2)

13003

Hôpital Euroépen Marseille, Marseille

38000

Centre de Chirurgie Gynecologique Et Des Maladies Du Sein, Grenoble

All Listed Sponsors
lead

Hôpital Européen Marseille

OTHER

NCT01742975 - Efficacy Study of Ifabond in Breast Cancer Surgery | Biotech Hunter | Biotech Hunter